NVCR NOVOCURE

Health Care · Russell 2000

Next earnings: not announced yet

What 9 analyst firms say about NOVOCURE: their latest ratings, price targets and how far the stock is from them. How it works

13.28 USD−0.27 (−1.99%) today

Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+68.2%to the avg target 22.33 USD+9.05 USD

Buy 3 · Hold 4 · Sell 0

7 rated views · 9 analyst/firm records · 9 firms

Latest report30 Oct 2026avg report date 30 Jul

Target rangePrice is below every target

now 13.28

Radar score

Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8021
Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8015

Recent analyst activity · last 90 days

Our tracked history has 5 reports on NVCR from 4 analyst firms in the last 90 days (9 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Evercore ISI lowered its target from $23.00 (set 23 Jul 2026) to $20.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

Firm	Analyst	Latest rating	Report date	Latest target (USD)
Evercore ISI	Vijay Kumar	Buy	23 Jul 2026	23.00 USD
H.C. Wainwright	Emily Bodnar	—	24 Jul 2026	32.00 USD
JPMorgan	Jessica Fye	Hold	13 Jul 2026	17.00 USD
Ladenburg Thalmann	Kevin M Degeeter	Buy	27 Feb 2026	27.00 USD
Piper Sandler	Jason Bednar	Buy	26 May 2026	—
Wedbush	David M Nierengarten	Hold	29 Oct 2026	20.00 USD
Weiss Ratings	Unnamed analyst	—	30 Oct 2026	—
Wells Fargo	Larry Biegelsen	Hold	30 Oct 2026	15.00 USD
Data feed RESEARCH	Research Team	Hold	24 Jul 2026	—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.